» Articles » PMID: 35908455

CT Findings of COVID-19-associated Pulmonary Aspergillosis: a Systematic Review and Individual Patient Data Analysis

Abstract

Purpose: Common CT abnormalities of pulmonary aspergillosis represent a cavity with air-meniscus sign, nodule, mass, and consolidation having an angio-invasive pattern. This study aims to conduct a systematic review and an individual patient-level image analysis of CT findings of COVID-19-associated pulmonary aspergillosis (CAPA).

Methods: A systematic literature search was conducted to identify studies reporting CT findings of CAPA as of January 7, 2021. We summarized study-level clinical and CT findings of CAPA and collected individual patient CT images by inviting corresponding authors. The CT findings were categorized into four groups: group 1, typical appearance of COVID-19; group 2, indeterminate appearance of COVID-19; group 3, atypical for COVID-19 without cavities; and group 4, atypical for COVID-19 with cavities. In group 2, cases had only minor discrepant findings including solid nodules, isolated airspace consolidation with negligible ground-glass opacities, centrilobular micronodules, bronchial abnormalities, and cavities.

Results: The literature search identified 89 patients from 25 studies, and we collected CT images from 35 CAPA patients (mean age 62.4 ± 14.6 years; 21 men): group 1, thirteen patients (37.1%); group 2, eight patients (22.9%); group 3, six patients (17.1%); and group 4, eight patients (22.9%). Eight of the 14 patients (57.1%) with an atypical appearance had bronchial abnormalities, whereas only one (7.1%) had an angio-invasive fungal pattern. In the study-level analysis, cavities were reported in 12 of 54 patients (22.2%).

Conclusion: CAPA can frequently manifest as COVID-19 pneumonia without common CT abnormalities of pulmonary aspergillosis. If abnormalities exist on CT images, CAPA may frequently accompany bronchial abnormalities.

Citing Articles

Severe mold fungal infections in critically ill patients with COVID-19.

Koulenti D, Paramythiotou E, Almyroudi M, Karvouniaris M, Markou N, Paranos P Future Microbiol. 2024; 19(9):825-840.

PMID: 38700287 PMC: 11290760. DOI: 10.2217/fmb-2023-0261.


Risk factors for COVID-19 associated pulmonary aspergillosis and outcomes in patients with acute respiratory failure in a respiratory sub-intensive care unit.

Iacovelli A, Oliva A, Mirabelli F, Giannone S, Laguardia M, Morviducci M BMC Infect Dis. 2024; 24(1):392.

PMID: 38605300 PMC: 11007928. DOI: 10.1186/s12879-024-09283-3.


COVID-19-associated pulmonary aspergillosis in intensive care unit: A real-life experience.

Russo A, Serraino R, Serapide F, Bruni A, Garofalo E, Longhini F Heliyon. 2024; 10(2):e24298.

PMID: 38293516 PMC: 10825494. DOI: 10.1016/j.heliyon.2024.e24298.


Imaging Findings in Aspergillosis: From Head to Toe.

Sousa C, Pasini R, Pasqualotto A, Marchiori E, Altmayer S, Irion K Mycopathologia. 2023; 188(5):623-641.

PMID: 37380874 DOI: 10.1007/s11046-023-00766-6.

References
1.
Witting C, Quaggin-Smith J, Mylvaganam R, Peigh G, Angarone M, Flaherty J . Invasive pulmonary aspergillosis after treatment with tocilizumab in a patient with COVID-19 ARDS: a case report. Diagn Microbiol Infect Dis. 2021; 99(4):115272. PMC: 7677089. DOI: 10.1016/j.diagmicrobio.2020.115272. View

2.
Gangneux J, Reizine F, Guegan H, Pinceaux K, Le Balch P, Prat E . Is the COVID-19 Pandemic a Good Time to Include Molecular Detection to Categorize Aspergillosis in ICU Patients? A Monocentric Experience. J Fungi (Basel). 2020; 6(3). PMC: 7558333. DOI: 10.3390/jof6030105. View

3.
Koehler P, Bassetti M, Chakrabarti A, Chen S, Colombo A, Hoenigl M . Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2020; 21(6):e149-e162. PMC: 7833078. DOI: 10.1016/S1473-3099(20)30847-1. View

4.
Arkel A, Rijpstra T, Belderbos H, van Wijngaarden P, Verweij P, Bentvelsen R . COVID-19-associated Pulmonary Aspergillosis. Am J Respir Crit Care Med. 2020; 202(1):132-135. PMC: 7328331. DOI: 10.1164/rccm.202004-1038LE. View

5.
Haglund A, Christensen S, Kristensen L, Gertsen J, Buus L, Lausch K . Invasive pulmonary aspergillosis and hyperthermia in an immunocompetent patient with COVID-19. Med Mycol Case Rep. 2020; 31:29-31. PMC: 7718585. DOI: 10.1016/j.mmcr.2020.11.004. View